EAU guidelines on penile cancer

European Urology

Volumn 46, Issue 1, 2004, Pages 1-8

  Solsona, E ^a   Algaba, F ^b   Horenblas, S ^c   Pizzocaro, G ^d   Windahl, T ^e  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b FUNDACIÓ PUIGVERT   (Spain)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^d Instituto Tumori   (Italy)

^e ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

Author keywords

Classification; Diagnosis; Follow up; Guidelines; Penile cancer; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; FLUOROURACIL; IMIQUIMOD; METHOTREXATE; VINCRISTINE;

ABDOMEN; AMPUTATION; BONE SCINTISCANNING; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CIRCUMCISION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CYTODIAGNOSIS; ECHOGRAPHY; FOLLOW UP; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS; PENIS CANCER; PENIS TUMOR; PHIMOSIS; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SURVIVAL TIME; THORAX RADIOGRAPHY;

EID: 2942566198     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.03.007     Document Type: Article

References (39)

1. Mobilio G., Ficarra V. Genital treatment of penile carcinoma. Curr. Opin. Urol. 11:2001;299-304
2. Sufrin G, Huben R. Benign and malignant lesions of the penis. In: Gillenwater JY, editor. Adult and Pediatric Urology, 2nd edition. Chicago: Year Book Medical Publisher; 1991, p. 1643.
3. Ornellas A.A., Seixas A.L.C., Marota A., Wisnescky A., Campos F., de Moraes J.R. Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J. Urol. 151:1994;1244-1249
4. Pizzocaro G., Piva L., Nicolai N. Treatment of lymphatic metastasis of squamous cell carcinoma of the penis at the National Tumour Institute of Mila. Arch. Ital. Urol. Androl. 68:1996;169-172
5. Culkin D.J., Beer T.M. Advanced penile carcinoma. J. Urol. 170:2003;359-365
6. Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penile. Part 2: the role and technique of lymph node dissection. BJU Int. 88:2001;473-483
7. Lopes A., Bezerra A.L., Serrano S.V., Hidalgo G.S. Iliac nodal metastases from carcinoma of the penis treated surgically. BJU Int. 86:2000;690-693
8. Ficarra V., Martignoni G., Maffei N., Cerruto M.A., Novara G., Cavalleri S., et al. Predictive pathological factors of lymph nodes involvement in the squamous cell carcinoma of the penis. Int. Urol. Nephrol. 34:2002;245-250
9. Slaton J.W., Morgenstern N., Levy D.A., Santos M.W. Jr., Tamboli R., Ro J.Y., et al. Tumour stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J. Urol. 165:2001;1138-1142
10. Ravi R. Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br. J. Urol. 72:1993;817-819
11. Schoen E.J., Oehrli M., Colby C., Machin G. The highly protective effect of newborn circumcision against invasive penile cancer. Pediatrics. 105:2000;E36
12. Bezerra A.L., Lopes A., Landman G., Alencar G.N., Torloni H., Villa L.L. Clinicopathologic features and human papillomavirus DNA prevalence of warty and squamous cell carcinoma of the penis. Am. J. Surg. Pathol. 25:2001;673-678
13. Pizzocaro G., Piva L., Bandieramonte G., Tana S. Up-to-date management of carcinoma of the penis. Eur. Urol. 32:1997;5-15
14. Lopes A., Hidalgo G.S., Kowallski L.P., Torloni H., Rossi B.M., Fonseca F.P. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J. Urol. 156:1996;1637-1642
15. Solsona E., Iborra I., Rubio J., Casanova J.L., Ricos J.V., Calabuig C. Prospective validation of the association of local tumour stage grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J. Urol. 165:2001;1506-1509
16. Stancik I., Holtl W. Penile cancer: review of the recent literature. Curr. Opin. Urol. 13:2003;467-472
17. Martins A.C., Faria S.M., Cologna A.J., Suaid H.J., Tucci S. Jr. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J. Urol. 167:2002;89-92
18. Lont A.P., Besnard A.P., Gallee M.P., van Tinteren H., Horenblas S. A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int. 91:2003;493-495
19. Tanis P.J., Lont A.P., Meinhardt W., Olmos R.A., Nieweg O.E., Horenblas S. Dynamic sentinel node biopsy for penile cancer: reliability of staging technique. J. Urol. 168:2002;76-80
20. Lont A.P., Horenblas S., Tanis P.J., Gallee M.P., van Tinteren H., Nieweg O.E. Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy. J. Urol. 170:2003;783-786
21. Windalh T., Andersson S.-O. Combined laser treatment for penile carcinoma: results after long-term follow-up. J. Urol. 169:2003;2118-2121
22. Bissada N.K., Yakout H.H., Fahmy W.E., Gayed M.S., Touijer A.K., Greene G.F., et al. Multi-institutional long-term experience with conservative surgery for invasive penile carcinoma. J. Urol. 169:2003;500-502
23. Ficarra V., Maffei N., Piacentine I., Al Rabi N., Cerruto M.A., Artibani W. Local treatment of penile squamous cell carcinoma. Urol. Int. 69:2002;169-173
24. Crook J., Grimard L., Tsihlias J., Morash C., Panzarella T. Interstitial brachytherapy for penile cancer: an alternative to amputation. J. Urol. 167:2002;506-511
25. Gotsadze D., Matveev B., Zak B., Mamaladze V. Is conservative organ-sparing treatment of penile carcinoma justified? Eur. Urol. 38:2000;306-312
26. Saint F., Legeais D., Leroy X., Biserte J., Gosselin B., Mazeman E. Therapeutic management of epidermoid carcinoma of the penis: anatomoclinical discussion and review of the literature. Prog. Urol. 10:2000;128-133. [French]
27. Horenblas S., van Tinteren H., Delemarre J.F.M., Boon T.A., Moonen L.M.F., Lustig W. Squamous cell carcinoma of the penis. II. Treatment of the primary tumour. J. Urol. 147:1992;1533-1538
28. Doehn C., Feyerabend T. Radiochemotherapy of penis carcinoma. Urology. 40:2001;313-314
29. Theodorescu D., Russo P., Zhang Z.F., Morash C., Fair W.F. Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes. J. Urol. 155:1996;1626-1631
30. Pizzocaro G, Piva L, Nicolai N. Improved management of nodal metastases of squamous cell carcinoma of the penis. J Urol 153 (1995) 246 [Abstract 69].
31. Kulkarni J.N., Kamat M.R. Prophylactic bilateral groin node dissection versus prophylactic radiotherapy and surveillance in patients with N0 and N1-2a carcinoma of the penis. Eur. Urol. 26:1994;123-128
32. Ravi R., Chaturvedt H.K., Sastry D.V. Role of radiation therapy in the treatment of carcinoma of the penis. Br. J. Urol. 74:1994;646-651
33. Agraval A., Pai D., Ananthakrishamn N., Smile S.R., Ratnakar C. The histological extent of the local spread of carcinoma of the penis and its therapeutic implications. BJU Int. 85:2000;299-301
34. Colberg J.W., Andriole G.L., Catalona W.J. Long-term follow-up of men undergoing modified inguinal lymphadenectomy for carcinoma of the penis. BJU. 79:1997;54-57
35. Bevan-Thomas R., Slaton J.W., Pettaway C.A. Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the MD Anderson Cancer Center Experience. J. Urol. 167:2002;1638-1642
36. Haas G.P., Blumenstein B.A., Gagliano R.G., Russell C.A., Rivkin S.E., Culkin D.J., et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group Study. J. Urol. 161:1999;1823-1825
37. Roth A.D., Berney C.R., Rohner S., Allal A.S., Morel P., Marti M.C., et al. Intra-arterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal: an active treatment modality with curative potential. Br. J. Cancer. 83:2000;1637-1642
38. Horenblas S., Newling D.W. Local recurrence tumour after penis-conserving therapy. A plea for long-term follow-up. Br. J. Urol. 72:1993;976-979
39. Lerner S.E., Jones J.G., Fleischmann J. Management of recurrent penile cancer following partial or total penectomy. Urol. Clin. North Am. 21:1994;729-737